This study demonstrates the relevance of HES6 in the development of androgen resistance and brings forward our understanding of how other factors co-operate with the master regulator of prostate cancer, the AR, to maintain essential pathways for cell survival. The gene discussed is AR; the disease is prostate carcinoma.